Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support
Key facts
- Where
- Changwon, Incheon, and Seoul, South KoreaSee the 6 sites
Where in South Korea
- Gyeongsang National University Changwon hospitalChangwon, South KoreaNot yet recruiting
- Samsung Medical Center Changwon HospitalChangwon, South KoreaNot yet recruiting
- Kwandong University Intl. ST. Mary's HospitalIncheon, South KoreaNot yet recruiting
- Eunpyeong St. Mary's HospitalSeoul, South KoreaNot yet recruiting
- Korea University Anam HospitalSeoul, South KoreaNot yet recruiting
- Samsung Medical CenterSeoul, South KoreaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Samsung Medical Center
- Trial code
- NCT07482865
- Record updated
- 23 October 2026
- Original description
A prospective, multi-center, open label, randomized controlled, superiority trial to compare clinical outcomes between routine distal perfusion catheter (DPC) insertion versus provisional distal perfusion catheter (DPC) insertion in the occurrence of sign or symptom of acute limb ischemia in patients undergoing mechanical circulatory support (MCS) through femoral artery approach.Read full original descriptionShow less
A prospective, multi-center, open label, randomized controlled, superiority trial to compare clinical outcomes between routine distal perfusion catheter (DPC) insertion versus provisional distal perfusion catheter (DPC) insertion in the occurrence of sign or symptom of acute limb ischemia in patients undergoing mechanical circulatory support (MCS) through femoral artery approach.
Inclusion: Patients aged 19 years old; Cardiogenic shock requiring mechanical circulatory support through femoral artery approach; Subject who can verbally confirm understandings of risks and benefits of receiving distal perfusion catheter insertion and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure; Under the critically-ill clinical circumstance (unclear consciousness of patient), legally authorized representative can provide written informed consent prior to any study related procedure.
Exclusion: Irreversible limb ischemia requiring interventional procedures or surgery at the time of MCS insertion; Previous history if femoral-femoral bypass grafting or femoral-popliteal bypass grafting; Previous history of limb amputation; Significant coagulopathy precluding invasive procedure due to high risk of bleeding; Apparent symptoms and sign of acute limb ischemia immediately after mechanical circulatory support insertion; Pregnant women, women with potential childbearing, or lactating women; Unwilling or unable to obtain informed consent from the participant or legally authorized representative.